Open AccessEffect of self-administered intraperitoneal bemiparin on peritoneal transport and ultrafiltration capacity in peritoneal dialysis patients with membrane dysfunction. A randomized, multi-centre open clinical trial
Author(s) -
Gloria del Peso,
M. Auxiliadora Bajo,
Miguel Pérez Fontán,
Javier Martínez,
Belén Marrón,
Rafael Selgas,
on behalf of the Group of Study on 'Bemidextrin'
Publication year - 2011
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfr546
Subject(s) - medicine , peritoneal dialysis , peritoneal equilibration test , surgery , ultrafiltration (renal) , complication , peritoneum , clinical trial , urology , creatinine , randomized controlled trial , continuous ambulatory peritoneal dialysis , chromatography , chemistry
Progressive peritoneal membrane injury and dysfunction are feared repercussions of peritoneal dialysis (PD), and may compromise the long-term feasibility of this therapy. Different strategies have been attempted to prevent or reverse this complication with limited success.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom